Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

angus_russell_questcor

Questcor hires Shire’s chief executive

June 11, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Questcor, Shire

Biopharma firm Questcor Pharmaceuticals has appointed the recently-retired chief executive of Shire to its Board of directors.   Angus Russell …
Appointment

Novartis works in MS switch

June 11, 2013 Research and Development, Sales and Marketing MS, Novartis, gilenya

Novartis’ oral MS drug Gilenya has been found to help multiple sclerosis (MS) patients who switch to it after taking …
News

High cure rate for Boehringer HCV drug

June 11, 2013 Research and Development, Sales and Marketing Boehringer Ingelheim, HCV

One of Boehringer Ingelheim’s pipeline drugs has achieved high response rates in patients with chronic genotype-1 hepatitis C virus (HCV) in …
News
astrazeneca image

AstraZeneca to pay up to $1.2 billion for Pearl

June 10, 2013 Research and Development, Sales and Marketing AstraZeneca, COPD, pearl therapeutics

AstraZeneca is betting big on lung disease specialist Pearl Therapeutics as it looks to spend $1.2 billion to acquire the …
News
Mid staffs image

Department of Health prioritises Francis response

June 7, 2013 Sales and Marketing DH, Francis, Mid Staffs, NHS

The Department of Health has set out its priorities for the next year, explaining how it will enhance public health …
News
Vifor image

Working Life, Vifor Pharma, Derek Williams

June 7, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vifor pharma, Working Life, williams

How did you find your way into your current role? I began my career in the UK as a sales …
Feature
Abilify image

NICE thumbs-up for Abilify

June 7, 2013 Sales and Marketing Abilify, BMS, NICE, Otsuka

Adolescents who suffer from bipolar disorder should be treated on the NHS with Otsuka Pharmaceuticals’ Abilify, according to draft guidance …
News
Novartis image

Novartis receives FDA warning

June 6, 2013 Manufacturing and Production, Sales and Marketing CGMP, FDA, GMP, Novartis

The FDA has castigated Novartis for what it calls ‘significant violations’ of current good manufacturing practice (CGMP) regulations for finished …
News
kim_sinil_4

Mirna appoints ex-Pfizer senior director

June 6, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, miRNA

Biotech firm Mirna Therapeutics has appointed Dr Sinil Kim as vice president of Oncology and chief medical officer. Kim will …
Appointment

Bayer takes over Conceptus

June 6, 2013 Sales and Marketing Bayer, Conceptus

The Bayer Group, which contains Bayer HealthCare, has taken over US contraception specialist Conceptus in a $1.1 billion deal. The …
News

Aveo to cut workforce after FDA knock-back

June 6, 2013 Research and Development, Sales and Marketing Aveo, FDA, cuts, tivozanib

Aveo will make major jobs cuts this year after news that a kidney cancer licence for its oncology drug tivozanib …
News

Novartis drug shows cancer promise

June 5, 2013 Research and Development, Sales and Marketing ASCO, Cancer, Novartis

A Novartis drug which has been given breakthrough therapy designation by the FDA has demonstrated early promise in patients with …
News
Celgene image

Celgene predicts trio of blockbusters

June 5, 2013 Sales and Marketing Celgene, Pomalidomide, Revlamid, Velcade

Europe’s medicines committee the CHMP has just adopted a positive opinion for Celgene’s new multiple myeloma treatment Pomalidomide Celgene (pomalidomide). …
News
dave_hunt

HAVAS LYNX makes several leadership changes

June 5, 2013 Medical Communications, Sales and Marketing Creative Lynx, HAVAS LYNX, PM Society Digital Awards

Comms agency HAVAS LYNX has realigned its senior team making a number of changes for the global firm as it …
Appointment
GSK image

GSK licences RA drug

June 5, 2013 Research and Development, Sales and Marketing GSK, RA, morphosys

GlaxoSmithKline is gambling millions of euros on an investigational drug in a bid to get an edge in the fight …
News
The Gateway to Local Adoption Series

Latest content

Vedana emerges with $46m funding to advance next-generation migraine therapies

June 26, 2026

Phase 1 study supports further development of inhaled respiratory therapy

June 25, 2026

PL BioScience appoints Maik Jornitz to Board of Directors

June 24, 2026

Axplora consolidates liver disease API manufacturing in India

June 23, 2026

Data suggests avapritinib improves quality of life for patients with mastocytosis

June 22, 2026